Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction

American Journal of Therapeutics

Volumn 17, Issue 4, 2010, Pages

  Wang, Norman C ^a   Piccini, Jonathan P ^b   Konstam, Marvin A ^c   Maggioni, Aldo P ^d   Traver, Brian ^e   Swedberg, Karl ^f   Udelson, James E ^c   Zannad, Faiez ^g   Cook, Thomas ^e   O'Connor, Christopher M ^h   Miller, Alan B ⁱ   Grinfeld, Liliana ^j   Gheorghiade, Mihai ^k  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d ANMCO RESEARCH CENTER   (Italy)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

^h DUKE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF FLORIDA   (United States)

^j HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^k NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

heart failure; hospitalization; implantable cardioverter defibrillator; outcomes; sudden death

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; UNITED STATES; DOUBLE BLIND PROCEDURE; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY;

AGED; DEFIBRILLATORS, IMPLANTABLE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77954965342     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181e70a65     Document Type: Article

References (21)

1. Braunwald E. Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360-1369.
2. RosamondW, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115: e69-e171.
3. Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: current state and framework for future research. Circulation. 2005;112:3958-3968. (Pubitemid 43739494)
4. Solomon SD, Dobson J, Pocock S, et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007;116:1482-1487.
5. Jencks SF, Milliams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-1428.
6. Cotter G, Felker M, Adams KF, et al. The pathophysiology of acute heart failure. Am Heart J. 2008;155:9-18.
7. Gheorghiade M, Pang P. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557-573.
8. Wang NC, Maggioni AP, Konstam MA, et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA. 2008;299:2656-2666.
9. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;53:1343-1382.
10. Ross JS, Mulvey GK, Stauffer B, et al. Statistical models and patient predictors of readmission for heart failure: a systematic review. Arch Intern Med. 2008;168:1371-1386.
11. Gheorghiade M, Orlandi C, Burnett JC Jr, et al. Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). J Card Fail. 2005;11:260-269.
12. Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007; 2978:1319-1331.
13. Gheorghiade M, Konstam MA, Burnett JC Jr, et al. Shortterm clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVERESTclinical status trials. JAMA. 2007;297:1332-1343.
14. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERITHF). Lancet. 1999;353:2001-2007.
15. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
16. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
17. O'Connor CM, Miller AB, Blair JEA, et al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Program. Am Heart J. 2010;159: 841-849.
18. The DAVID Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288:3115-3123.
19. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017.
20. Hernandez AF, Fonarow GC, Hammill BG, et al. Clinical effectiveness of implantable cardioverter-defibrillators among Medicare beneficiaries with heart failure. Circ Heart Fail. 2010;3:7-13.
21. Stevenson LW, Desai AS. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure. J Card Fail. 2006;12:407-412.